The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Wang, J., Wang, J., Sun, Y., Song, W., Nor, J. E., Wang, C. Y., & Taichman, R. S. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.022 · Cited by 160
RetractedA Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Wang, J., Wang, J., Dai, J., Jung, Y., Wei, C.-L., Wang, Y., Havens, A. M., Hogg, P. J., Keller, E. T., Pienta, K. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2971 · Cited by 152
Self-citationRetractedLiao, A., Shi, R., Jiang, Y., Tian, S., Li, P., Song, F., Qu, Y., Li, J., Yun, H., & Yang, X. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9006-0 · Cited by 40
RetractedLiao, A., Shi, R., Jiang, Y., Tian, S., Li, P., Song, F., Qu, Y., Li, J., Yun, H., & Yang, X. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0508-4 · Cited by 7
RetractedSiegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
Yu, Y., Xiao, C.-H., Tan, L.-D., Wang, Q.-S., Li, X.-Q., & Feng, Y.-M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.768 · Cited by 676
The Intricate Role of CXCR4 in Cancer
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-411638-2.00002-1 · Cited by 672
Co-evolution of tumor cells and their microenvironment
Polyak, K., Haviv, I., & Campbell, I. G. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.10.012 · Cited by 628
Structure and Chromosomal Localization of the Human Stromal Cell-Derived Factor 1 (SDF1) Gene
Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., & Honjo, T. (1995) · Genomics · doi:10.1006/geno.1995.1180 · Cited by 624
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 613
Zeng, Z., Xi Shi, Y., Samudio, I. J., Wang, R.-Y., Ling, X., Frolova, O., Levis, M., Rubin, J. B., Negrin, R. R., Estey, E. H., et al. (2009) · Blood · doi:10.1182/blood-2008-05-158311 · Cited by 518
Nervi, B., Ramirez, P., Rettig, M. P., Uy, G. L., Holt, M. S., Ritchey, J. K., Prior, J. L., Piwnica-Worms, D., Bridger, G., Ley, T. J., et al. (2009) · Blood · doi:10.1182/blood-2008-06-162123 · Cited by 491
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 464
Chen, Y., Ramjiawan, R. R., Reiberger, T., Ng, M. R., Hato, T., Huang, Y., Ochiai, H., Kitahara, S., Unan, E. C., Reddy, T. P., et al. (2015) · Hepatology · doi:10.1002/hep.27665 · Cited by 451
Shaked, Y., Henke, E., Roodhart, J. M. L., Mancuso, P., Langenberg, M. H. G., Colleoni, M., Daenen, L. G., Man, S., Xu, P., Emmenegger, U., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.001 · Cited by 440
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Kryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
Konopleva, M. Y., & Jordan, C. T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0904 · Cited by 402
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
Kulbe, H., Thompson, R., Wilson, J. L., Robinson, S., Hagemann, T., Fatah, R., Gould, D., Ayhan, A., & Balkwill, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2941 · Cited by 386
Zhang, Y., Yang, P., Sun, T., Li, D., Xu, X., Rui, Y., Li, C., Chong, M., Ibrahim, T., Mercatali, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2690 · Cited by 350
Epithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 337
Barbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G., Spaziante, R., Florio, T., & Schettini, G. (2003) · PubMed · Cited by 336
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., & Shim, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.182 · Cited by 334
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Kryczek, I., Wei, S., Keller, E., Liu, R., & Zou, W. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2006 · Cited by 329
Hall, J. M., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0438 · Cited by 293
Righi, E., Kashiwagi, S., Yuan, J., Santosuosso, M., Leblanc, P., Ingraham, R., Forbes, B., Edelblute, B., Collette, B., Xing, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3143 · Cited by 245
Hoellenriegel, J., Zboralski, D., Maasch, C., Rosin, N. Y., Wierda, W. G., Keating, M. J., Kruschinski, A., & Burger, J. A. (2014) · Blood · doi:10.1182/blood-2013-03-493924 · Cited by 242
Ping, Y., Yao, X., Jiang, J., Zhao, L., Yu, S., Jiang, T., Lin, M. C., Chen, J., Wang, B., Zhang, R., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2908 · Cited by 226
Kajiyama, H., Shibata, K., Terauchi, M., Ino, K., Nawa, A., & Kikkawa, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23083 · Cited by 220
The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease
Karin, N. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909602 · Cited by 217
CXCR7 impact on CXCL12 biology and disease
Sánchez-Martín, L., Sánchez-Mateos, P., & Cabañas, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.004 · Cited by 206
Guyon, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00065 · Cited by 206
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
Ganzfried, B. F., Riester, M., Haibe-Kains, B., Risch, T., Tyekucheva, S., Jazic, I., Wang, X. V., Ahmadifar, M., Birrer, M. J., Parmigiani, G., et al. (2013) · Database · doi:10.1093/database/bat013 · Cited by 200
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Domanska, U. M., Timmer-Bosscha, H., Nagengast, W. B., Oude Munnink, T. H., Kruizinga, R. C., Ananias, H. J. K., Kliphuis, N. M., Huls, G., De Vries, E. G. E., de Jong, I. J., et al. (2012) · Neoplasia · doi:10.1593/neo.12324 · Cited by 191
Li, X., Ma, Q., Xu, Q., Liu, H., Lei, J., Duan, W., Bhat, K., Wang, F., Wu, E., & Wang, Z. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.035 · Cited by 181
Kim, J., Mori, T., Chen, S. L., Amersi, F. F., Martinez, S. R., Kuo, C., Turner, R. R., Ye, X., Bilchik, A. J., Morton, D. L., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217690.65909.9c · Cited by 175
Jiang, Y.-P., Wu, X.-H., Shi, B., Wu, W.-X., & Yin, G.-R. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.02.036 · Cited by 173
Beider, K., Bitner, H., Leiba, M., Gutwein, O., Koren-Michowitz, M., Ostrovsky, O., Abraham, M., Wald, H., Galun, E., Peled, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2207 · Cited by 171
Uchida, D., Begum, N.-M., Almofti, A., Nakashiro, K.-I., Kawamata, H., Tateishi, Y., Hamakawa, H., Yoshida, H., & Sato, M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00344-6 · Cited by 168
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Zhao, E., Wang, L., Dai, J., Kryczek, I., Wei, S., Vatan, L., Altuwaijri, S., Sparwasser, T. D., Wang, G., Keller, E. T., et al. (2012) · OncoImmunology · doi:10.4161/onci.1.2.18480 · Cited by 161
Jeon, E. S., Moon, H. J., Lee, M. J., Song, H. Y., Kim, Y. M., Cho, M., Suh, D.-S., Yoon, M.-S., Chang, C. L., Jung, J. S., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0742 · Cited by 161
Xu, L., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., Samuel, R., Shellito, P., Czito, B. G., Lin, P.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2099 · Cited by 161
Porcile, C., Bajetto, A., Barbieri, F., Barbero, S., Bonavia, R., Biglieri, M., Pirani, P., Florio, T., & Schettini, G. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.024 · Cited by 159
Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 159
Wei, S., Kryczek, I., Edwards, R. P., Zou, L., Szeliga, W., Banerjee, M., Cost, M., Cheng, P., Chang, A., Redman, B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0565 · Cited by 159
Moskovits, N. B.-C., Kalinkovich, A., Bar, J., Lapidot, T., & Oren, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2323 · Cited by 155
Gil, M., Komorowski, M. P., Seshadri, M., Rokita, H., McGray, A. R., Opyrchal, M., Odunsi, K. O., & Kozbor, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400201 · Cited by 153
Taverna, S., Amodeo, V., Saieva, L., Russo, A. D., Giallombardo, M., Leo, G. D., & Alessandro, R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-169 · Cited by 150
Hu, T., Yao, Y., Yu, S., Han, L., Wang, W., Guo, H., Tian, T., Ruan, Z.-P., Kang, X., Wang, J., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.012 · Cited by 149
Infantino, S., Moepps, B., & Thelen, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2197 · Cited by 148
SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy
Roccaro, A. M., Sacco, A., Purschke, W. G., Moschetta, M., Buchner, K., Maasch, C., Zboralski, D., Zöllner, S. K., Vonhoff, S., Mishima, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.042 · Cited by 148
Gil, M., Seshadri, M., Komorowski, M. P., Abrams, S. I., & Kozbor, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220580110 · Cited by 147
Conley‐LaComb, M. K., Saliganan, A. D., Kandagatla, P., Chen, Y. Q., Cher, M. L., & Chinni, S. R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-85 · Cited by 146
Niedermeier, M., Hennessy, B. T., Knight, Z. A., Henneberg, M., Hu, J., Kurtova, A. V., Wierda, W. G., Keating, M. J., Shokat, K. M., & Burger, J. A. (2009) · Blood · doi:10.1182/blood-2008-06-165068 · Cited by 142
Jee, S., Chu, C., Chiu, H.-C., Huang, Y., Tsai, W.-L., Liao, Y., & Kuo, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23497.x · Cited by 139
CXCR4 Inhibition Synergizes with Cytotoxic Chemotherapy in Gliomas
Redjal, N., Chan, J. A.-W., Segal, R. A., & Kung, A. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1372 · Cited by 138
Huang, Z., Shi, T., Zhou, Q., Shi, S., Zhao, R., Shi, H. S., Dong, L., Zhang, C., Zeng, K., Chen, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304213 · Cited by 135
Yoon, Y., Liang, Z., Zhang, X., Choe, M., Zhu, A., Cho, H. T., Shin, D. M., Goodman, M. M., Chen, Z., & Shim, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2263 · Cited by 134
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Ko, S. Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., & Naora, H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62229 · Cited by 132
Zannettino, A. C. W., Bühring, H., Niutta, S., Watt, S. M., Benton, M. A., & Simmons, P. J. (1998) · Blood · doi:10.1182/blood.v92.8.2613 · Cited by 130
Heinrich, E. L., Lee, W., Lu, J., Lowy, A. M., & Kim, J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-68 · Cited by 129
SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
Uygur, B., & Wu, W.-S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-139 · Cited by 129
miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration
Staton, A. A., Knaut, H., & Giráldez, A. J. (2011) · Nature Genetics · doi:10.1038/ng.758 · Cited by 129
MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1α
Leone, V., D’Angelo, D., Rubio, I. G. S., de Freitas, P. M., Federico, A., Colamaio, M., Pallante, P., Medeiros-Neto, G. A., & Fusco, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0345 · Cited by 124
Yu, T., Liu, K., Wu, Y., Fan, J., Chen, J., Li, C., Yang, Q., & Wang, Z. (2013) · Oncogene · doi:10.1038/onc.2013.448 · Cited by 121
Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner
Zhu, S., Sachdeva, M., Wu, F., Lu, Z., & Mo, Y.-Y. (2009) · Oncogene · doi:10.1038/onc.2009.459 · Cited by 119
Boudot, A. J., Kerdivel, G., Habauzit, D., Eeckhoute, J., Dily, F. L., Flouriot, G., Samson, M., & Pakdel, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020898 · Cited by 117
Shen, P., Chen, X., Liao, Y., Chen, N., Zhou, Q., Wei, Q., Li, X., Wang, J., & Zeng, H. (2014) · The Prostate · doi:10.1002/pros.22795 · Cited by 115
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
Popple, A. L., Durrant, L. G., Spendlove, I., Rolland, P. D., Scott, I., Deen, S., & Ramage, J. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.49 · Cited by 115
Wang, Z., Ma, Q., Liu, Q., Yu, H., Zhao, L., Shen, S., & Yao, J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604745 · Cited by 112
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
Rigo, A., Gottardi, M., Zamò, A., Mauri, P., Bonifacio, M., Krampera, M., Damiani, E., Pizzolo, G., & Vinante, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-273 · Cited by 112
CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
Wagner, P. L., Hyjek, E. M., Vazquez, M., Meherally, D., Liu, Y. F., Chadwick, P. A., Rengifo, T. P., Sica, G., Port, J. L., Lee, P. C., et al. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.07.039 · Cited by 111
Kojima, K., McQueen, T. J., Chen, Y., Jacamo, R. O., Konopleva, M. Y., Shinojima, N., Shpall, E. J., Huang, X., & Andreeff, M. (2011) · Blood · doi:10.1182/blood-2011-02-334136 · Cited by 109
Martin, S. K., Diamond, P., Williams, S. A., To, L. B., Peet, D. J., Fujii, N., Gronthos, S., Harris, A. L., & Zannettino, A. C. W. (2009) · Haematologica · doi:10.3324/haematol.2009.015628 · Cited by 105
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
Liu, S.-C., Alomran, R., Chernikova, S. B., Lartey, F. M., Stafford, J. H., Jang, T., Merchant, M. J., Zboralski, D., Zöllner, S. K., Kruschinski, A., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not149 · Cited by 103
miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma
Lü, J., Luo, H., Liu, X., Peng, Y., Zhang, B., Wang, L., Xu, X., Peng, X., Li, G., Tian, W., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt354 · Cited by 99
Bignotti, E., Tassi, R. A., Calza, S., Ravaggi, A., Bandiera, E., Rossi, E., Donzelli, C., Pasinetti, B., Pecorelli, S. L., & Santin, A. D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.10.874 · Cited by 96
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
Romain, B., Hachet‐Haas, M., Rohr, S., Brigand, C., Galzi, J., Gaub, M., Pencreach, E., & Guénot, D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-58 · Cited by 94
Porcile, C., Bajetto, A., Barbero, S., PIRANI, P., & Schettini, G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.021 · Cited by 92
Rehman, A. O., & Wang, C. (2009) · International Journal of Oral Science · doi:10.4248/ijos.09059 · Cited by 90
CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
Lin, L., Mm, H., Wang, F., Ll, X., Hx, Y., & Py, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.392 · Cited by 86
Barbieri, F., Bajetto, A., & Florio, T. (2009) · Journal of Oncology · doi:10.1155/2010/426956 · Cited by 85
Liu, Y., Zhou, Y., Feng, X., An, P., Quan, X., Wang, H., Ye, S., Yu, C., He, Y., & Luo, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2168 · Cited by 85
Ramakrishnan, M., Mathur, S. R., & Mukhopadhyay, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0896 · Cited by 85
Vater, A., Sahlmann, J., Kröger, N., Zöllner, S. K., Lioznov, M. V., Maasch, C., Buchner, K., Vossmeyer, D., Schwoebel, F., Purschke, W. G., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.58 · Cited by 84
Duan, F., Qian, F., Fang, K., Lin, K., Wang, W., & Chen, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-164 · Cited by 83
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
Thomas, R. M., Kim, J., Revelo-Penafiel, M. P., Angel, R., Dawson, D. W., & Lowy, A. M. (2008) · Gut · doi:10.1136/gut.2007.143941 · Cited by 83
Bartolomé, R. A., Ferreiro, S., Miquilena-Colina, M. E., Martínez‐Prats, L., Soto‐Montenegro, M. L., García‐Bernal, D., Vaquero, J. J., Agami, R., Delgado, R. B., Desco, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080636 · Cited by 82
Toritsuka, M., Kimoto, S., Muraki, K., Landek‐Salgado, M. A., Yoshida, A., Yamamoto, N., Horiuchi, Y., Hiyama, H., Tajinda, K., Ni, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312661110 · Cited by 80
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Kwong, J., Kulbe, H., Wong, D., Chakravarty, P., & Balkwill, F. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0966 · Cited by 79
Deutsch, A. J. A., Steinbauer, E., Hofmann, N., Strunk, D., Gerlza, T., Beham‐Schmid, C., Schaider, H., & Neumeister, P. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.134 · Cited by 78
Yang, B., Tanaka, T. T., Jang, M. H., Bai, Z., Hayasaka, H., & Miyasaka, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4376 · Cited by 78
Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells
Forde, S. P., Tye, B. J., Newey, S. E., Roubelakis, M. G., Smythe, J., McGUCKIN, C. P., Pettengell, R., & Watt, S. M. (2006) · Blood · doi:10.1182/blood-2006-05-023028 · Cited by 76
Hsieh, J.-Y., Huang, T.-S., Cheng, S., Lin, W., Tsai, T.-N., Lee, O. K., & Wang, H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt666 · Cited by 74
Kawaguchi, A., Orba, Y., Kimura, T., Iha, H., Ogata, M., Tsuji, T., Ainai, A., Sata, T., Okamoto, T., Hall, W. W., et al. (2009) · Blood · doi:10.1182/blood-2008-11-189308 · Cited by 71
Ovulation and extra-ovarian origin of ovarian cancer
Yang‐Hartwich, Y., Gurrea-Soteras, M., Sumi, N. J., Joo, W. D., Holmberg, J. C., Craveiro, V., Alvero, A. B., & Mor, G. (2014) · Scientific Reports · doi:10.1038/srep06116 · Cited by 71
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.
Ghanem, I., Riveiro, M. E., Paradis, V., Faivre, S. J., de Parga, P. V., & Raymond, É. (2014) · PubMed Central · Cited by 70
Luo, H., Wang, Z., Sheng, Y., Zhang, Q. H., Yan, J., Hou, J., Zhu, K., Cheng, Y., Xu, Y., Zhang, X., et al. (2013) · Medical Oncology · doi:10.1007/s12032-013-0789-z · Cited by 69
Liu, Z., Ye, P., Wang, S., Wu, J., Sun, Y., Zhang, A., Ren, L., Cheng, C., Huang, X., Wang, K., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000598 · Cited by 69
Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer
Ramos, E. A. D. S., Grochoski, M., Braun-Prado, K., Seniski, G. G., Cavalli, I. J., Ribeiro, E. M. S. F., Camargo, A. A., Costa, F. F., & Klassen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029461 · Cited by 67
Ramos, E. A., Camargo, A. A., Braun-Prado, K., Slowik, R., Cavalli, I. J., Ribeiro, E. M. S. F., Pedrosa, F. D. O., de Souza, E. M., Costa, F. F., & Klassen, G. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-23 · Cited by 67
The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
Li, X., Li, P., Chang, Y., Xu, Q., Wu, Z., Ma, Q., & Wang, Z. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2020-8 · Cited by 66
Iwasa, S., Yanagawa, T., Fan, J., & Katoh, R. (2009) · PubMed · Cited by 66
The CXCR4/CXCL12 axis in endometrial cancer
Gelmini, S., Mangoni, M., Castiglione, F., Beltrami, C., Pieralli, A., Andersson, K. L., Fambrini, M., Taddei, G. L., Serio, M., & Orlando, C. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9240-4 · Cited by 65
Liang, J. J., Zhu, S., Bruggeman, R., Zaino, R. J., Evans, D. B., Fleming, J. B., Gomez, H. F., Zander, D. S., & Wang, H. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0405 · Cited by 65
Buechli, M. E., LaMarre, J., & Koch, T. G. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0411 · Cited by 64
Guo, L., Cui, Z., Zhang, J., & Huang, Y. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10490 · Cited by 62
Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma
Barbolina, M. V., Kim, M., Liu, Y., Shepard, J. A., Belmadani, A. A., Miller, R. J., Shea, L. D., & Stack, M. S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0463 · Cited by 62
Sarchio, S. N. E., Scolyer, R. A., Beaugie, C., McDonald, D. M., Marsh‐Wakefield, F., Halliday, G. M., & Byrne, S. N. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.424 · Cited by 61
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
de Nigris, F., Schiano, C., Infante, T., & Claudio Napoli, A. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212801820039 · Cited by 61
Liu, F., Lang, R., Wei, J., Fan, Y., Cui, L., Gu, F., Guo, X., Pringle, G. A., Zhang, X., & Fu, L. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03289.x · Cited by 61
Wu, M., Chen, Q., Li, D., Li, X., Li, X., Huang, C., Tang, Y., Zhou, Y., Wang, D., Tang, K., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21400 · Cited by 59
MiR-886-3p Down Regulates CXCL12 (SDF1) Expression in Human Marrow Stromal Cells
Pillai, M. M., Yang, X., Balakrishnan, I., Bemis, L., & Torok‐Storb, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014304 · Cited by 58
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
Spinello, I., Quaranta, M. T., Riccioni, R., Riti, V., Pasquini, L., Boe, A., Pelosi, E., Vitale, A., Foà, R., Testa, U., et al. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.24 · Cited by 57
Peng, Y., Wang, G., Huo, H., Li, Q., Zhao, Y., & Liu, Y. (2014) · Medical Oncology · doi:10.1007/s12032-014-0377-x · Cited by 57
Ratajczak, M. Z., Jadczyk, T., Schneider, G., Kakar, S. S., & Kucia, M. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-95 · Cited by 56
Huang, Y., Zhang, J., Cui, Z., Zhao, J., & Ye, Z. (2012) · 癌症:英文版 · doi:10.5732/cjc.012.10063 · Cited by 52
Heckmann, D., Maier, P., Laufs, S., Li, L., Sleeman, J. P., Trunk, M. J., Leupold, J. H., Wenz, F. K., Zeller, W. J., Früehauf, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0582 · Cited by 49
Douglass, S. M., Meeson, A. P., Overbeck‐Zubrzycka, D., Brain, J. G., Bennett, M. R., Lamb, C. A., Lennard, T. W. J., Browell, D., Ali, S., & Kirby, J. A. (2014) · The Journal of Pathology · doi:10.1002/path.4381 · Cited by 48
Yu, Z. H., Chen, J., Zhang, S., Chang, X., Ma, J., & Dai, D. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1922-5 · Cited by 48
SDF-1/CXCR7 Axis Enhances Ovarian Cancer Cell Invasion by MMP-9 Expression Through p38 MAPK Pathway
Yu, Y., Li, H., Xue, B., Jiang, X., Huang, K., Ge, J., Zhang, H., & Chen, B. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2289 · Cited by 47
Chu, C., Cha, S.-T., Lin, W.-C., Lu, P., Tan, C., Chang, C.-C., Lin, B.-R., Jee, S., & Kuo, M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn228 · Cited by 47
Yu, Y., & Xiaoyan, X. (2007) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000236259.88146.a4 · Cited by 45
Thiele, S., Mungalpara, J., Steen, A., ROSENKILDE, M. M., & Våbenø, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12842 · Cited by 44
Lü, M.-H., Hu, C.-J., Chen, L., Peng, X., Chen, J., Hu, J.-Y., Teng, M., & Liang, G.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068972 · Cited by 43
Tang, J., Zhang, L., She, X., Zhou, G., Yu, F., Xiang, J., & Li, G. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.666692 · Cited by 42
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
Huang, A.-F., Chen, M.-W., Huang, S.-M., Kao, C.-L., Lai, H., & Chan, J. Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-115 · Cited by 42
Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
Salomonnson, E., Stacer, A. C., Ehrlich, A., Luker, K. E., & Luker, G. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051500 · Cited by 39
Lim, J., & Chung, H. W. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.010 · Cited by 37
Structural basis for C-ribosylation in the alnumycin A biosynthetic pathway
Oja, T., Niiranen, L., Sandalova, T., Klika, K. D., Niemi, J., Mäntsälä, P., Schneider, G., & Metsä‐Ketelä, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207407110 · Cited by 36
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia
Crowther-Swanepoel, D., Qureshi, M., Dyer, M. J. S., Matutes, E., Dearden, C. E., Catovsky, D., & Houlston, R. S. (2009) · Blood · doi:10.1182/blood-2009-07-235184 · Cited by 34
Monteagudo, C. C., Ramos, D., Pellín-Carcelén, A., Gil, R., Callaghan, R. C., Martín, J. M., Alonso, V., Murgui, A., Navarro, L., Fariñas, S. C., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9476-2 · Cited by 33
miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells.
Zhou, J., Liu, R., Wang, Y., Tang, J., Tang, S., Chen, X., Xia, K., Xiong, W., Xu, D., Wang, S., et al. (2014) · PubMed · Cited by 32
Self-citationCXCL12 expression by healthy and malignant ovarian epithelial cells
Machelon, V., Gaudin, F., Camilleri‐Broët, S., Nasreddine, S., Bouchet‐Delbos, L., Pujade-Lauraine, É., Alexandre, J., Gladieff, L., Arenzana‐Seisdedos, F., Émilie, D., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-97 · Cited by 29
Chemokine Receptor CXCR7 Is a Functional Receptor for CXCL12 in Brain Endothelial Cells
Liu, Y., Carson-Walter, E. B., & Walter, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103938 · Cited by 29
Madden, S. F., Clarke, C., Stordal, B., Carey, M. S., Broaddus, R. R., Gallagher, W. M., Crown, J. P., Mills, G. B., & Hennessy, B. T. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-241 · Cited by 29
Tsukamoto, H., Shibata, K., Kajiyama, H., Terauchi, M., Nawa, A., & Kikkawa, F. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9079-5 · Cited by 26
Xu, M., Li, W., Xu, Y., & Xinming, C. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00801.x · Cited by 26
Archibald, K. M., Kulbe, H., Kwong, J., Chakravarty, P., Temple, J., Chaplin, T., Flak, M. B., McNeish, I. A., Deen, S., Brenton, J. D., et al. (2012) · Oncogene · doi:10.1038/onc.2011.653 · Cited by 26
Perim, A. D. L., Guembarovski, R. L., Oda, J. M. M., Lopes, L. F., Ariza, C. B., Amarante, M. K., Fungaro, M. H. P., de Oliveira, K. B., & Watanabe, M. A. E. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2551-1 · Cited by 23
Mast Cells Mediate the Immune Suppression Induced by Dermal Exposure to JP-8 Jet Fuel
Limón-Flores, A. Y., Chacón‐Salinas, R., Ramos, G., & Ullrich, S. E. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp181 · Cited by 23
AMD3100 protects from UV-induced skin cancer
Byrne, S. N., & Sarchio, S. N. E. (2014) · OncoImmunology · doi:10.4161/onci.27562 · Cited by 16
A taxonomy of organ-specific breast cancer metastases based on a protein–protein interaction network
Pamplona, R. S., García-García, J., Franco, S., Messeguer, X., Driouch, K., Oliva, B., & Sierra, À. (2012) · Molecular BioSystems · doi:10.1039/c2mb25104c · Cited by 12
Yu, Y., Shi, X., Shu, Z., Xie, T., Huang, K., Wei, L., Song, H., Zhang, W., & Xue, X. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x13907540404879 · Cited by 12
Self-citationAbsence of activating mutations of CXCR4 in pituitary tumours
Lee, Y., Noh, T. W., Lee, M. K., Jameson, J. L., & Lee, E. J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03629.x · Cited by 10
Genetic and cytokine changes associated with symptomatic stages of CLL
Agarwal, A., Cooke, L., Riley, C., Qi, W., Mount, D. W., & Mahadevan, D. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.05.017 · Cited by 9
Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells
Pietkiewicz, P., Lutkowska, A., Lianeri, M., & Jagodziński, P. P. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.04.041 · Cited by 9
Cited by
Clinical relevance of tumour-associated macrophages
Pittet, M. J., Michielin, O., & Migliorini, D. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00620-6 · Cited by 731
mTORC1 and mTORC2 in cancer and the tumor microenvironment
Kim, L. C., Cook, R. S., & Chen, J. (2017) · Oncogene · doi:10.1038/onc.2016.363 · Cited by 444
The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Ghalehbandi, S., Yuzugulen, J., Pranjol, M. Z. I., & Pourgholami, M. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175586 · Cited by 362
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration
Bianchi, M. E., & Mezzapelle, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02109 · Cited by 335
Srivastava, S., Furlan, S. N., Jaeger-Ruckstuhl, C. A., Sarvothama, M., Berger, C., Smythe, K. S., Garrison, S. M., Specht, J. M., Lee, S. M., Amezquita, R. A., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.11.005 · Cited by 324
Metadata
- Authors
- Guo, F., Wang, Y., Liu, J., Mok, S. C., Xue, F., & Zhang, W.
- Venue
- Oncogene
- Published
- 2015-05-11
- Volume
- 35
- Issue
- 7
- Pages
- 816-826
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2128645075
- Cited by
- 468
- References
- 160
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.